High Levels of Galectin-3 and Uric Acid Are Independent Predictors of Renal Impairment in Patients with Stable Coronary Artery Disease
Authors:
- Nayleth Leal-PérezNLNayleth Leal-Pérez
- Luis M. Blanco-ColioLuis M. Blanco-Colio
- José Luis Martín-VenturaJMJosé Luis Martín-Ventura
- Carlos Gutiérrez-LandaluceCarlos Gutiérrez-Landaluce
- Ignacio Mahíllo-FernándezIMIgnacio Mahíllo-Fernández
- María Luisa González-CasausMGMaría Luisa González-Casaus
- Óscar LorenzoÓscar Lorenzo
- Jesús EgidoJEJesús Egido
- José TuñónJosé Tuñón
Open Access
- 25 July 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5264
Abstract
Background: High plasma levels of Galectin-3 (Gal-3) and uric acid (UA) are associated with a decline in renal function in different populations. However, this association has not yet been studied in patients with coronary artery disease (CAD). Methods: We included 556 patients with stable CAD. Plasma levels of Gal-3, UA, N-Terminal probrain natriuretic peptide (NT-proBNP), calcidiol, fibroblast growth factor 23, phosphate, parathormone, and klotho were assessed at baseline. The primary outcome was the percentage decrease in eGFR; the secondary outcomes were the absolute decrease in eGFR and achieving a reduction of ≥20% in this parameter. Results: Age was 63.1 ± 12.2 years, and 73.9% of patients were male. The median eGFR was 86.77 (72.27, 97.85) mL/min/1.73 m2. After 3.47 (2.10–5.72) years of follow-up, eGFR declined by 3.62% [−2.07–13.82]. Baseline UA (0.012 [CI95% 0.003, 0.020]; p = 0.008), Gal-3 (0.0153 [CI95% 0.001, 0.029]; p = 0.037), and NT-proBNP (0.017 [CI95% 0.000–0.025]; p = 0.027) were independent positive predictors of the percentage decrease in eGFR, while calcidiol (−0.005 [CI95% −0.009, −0.002]; p = 0.005) was an inverse predictor of this outcome. Similarly, UA and Gal-3 were positive independent predictors of the absolute decline in eGFR (0.009 [0.003, 0.017]; p = 0.004 and 0.012 [0.001, 0.023]; p = 0.031, respectively), while calcidiol was inversely associated (−0.003 [−0.005]–[−0.001]; p = 0.020). Uric acid (1.237 [1.046–1.463]; p = 0.013) and NT-proBNP (1.000 [1.000–1.001]; p = 0.049) levels were positive independent predictors of a ≥20% decrease in eGFR. In patients with eGFR ≥ 60 mL/min/1.73 m2, UA was the only biomarker independently associated with renal function decline. Conclusions: In patients with CAD and normal or mildly reduced renal function, UA and Gal-3 plasma levels are independent positive predictors of a future decrease in eGFR. These findings could lead to a change in the approach to patients with CAD in the future.Keywords
Funding Information
- Instituto de Salud Carlos III (ISCIII) (PI14/01567, PI17/01495, PI20/00923, PI20/00487, PI23/00119, PI24/00978, PI22/00233, RTC2019-006826-1, RD09/0076/00101)
- European Union (PI14/01567, PI17/01495, PI20/00923, PI20/00487, PI23/00119, PI24/00978, PI22/00233, RTC2019-006826-1, RD09/0076/00101)
- Ministry of Science and Innovation (PI14/01567, PI17/01495, PI20/00923, PI20/00487, PI23/00119, PI24/00978, PI22/00233, RTC2019-006826-1, RD09/0076/00101)
- spanish society of cardiology (PI14/01567, PI17/01495, PI20/00923, PI20/00487, PI23/00119, PI24/00978, PI22/00233, RTC2019-006826-1, RD09/0076/00101)
- Institute of heart de Salud Carlos III FEDER (PI14/01567, PI17/01495, PI20/00923, PI20/00487, PI23/00119, PI24/00978, PI22/00233, RTC2019-006826-1, RD09/0076/00101)
This publication has 60 references indexed in Scilit:
- Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approachesJournal of Molecular Medicine, 2021
- Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitusDiabetologia, 2018
- Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: A meta-analysisAtherosclerosis, 2016
- Time to target uric acid to retard CKD progressionClinical and Experimental Nephrology, 2016
- Parathormone levels are independently associated with the presence of left ventricular hypertrophy in patients with coronary artery diseaseThe Journal of nutrition, health and aging, 2016
- Plasma Calcidiol, Calcitriol, and Parathyroid Hormone and Risk of New Onset Heart Failure in a Population-Based Cohort StudyESC Heart Failure, 2016
- Parathyroid hormone concentration and risk of cardiovascular diseases: The Atherosclerosis Risk in Communities (ARIC) studyAmerican Heart Journal, 2014
- Usefulness of a Combination of Monocyte Chemoattractant Protein-1, Galectin-3, and N-Terminal Probrain Natriuretic Peptide to Predict Cardiovascular Events in Patients With Coronary Artery DiseaseThe American Journal of Cardiology, 2014
- Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney DiseaseJAMA, 2011
- Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged MenArchives of internal medicine (1960), 2004